1-3 of 3
Daniel Tannenbaum, B.S.
Close
Save search
Sort by
Journal Articles

CRM1 Inhibition Abrogates Osteoclast Formation and Bone Resorption Via Inhibition of RANKL-Induced NFκB While Sparing Osteoblastogenesis: Further Therapeutic Implication in Multiple Myeloma

Free
Chirag Acharya, MD, Mike Y Zhong, B.S., Yolanda Calle, PhD, Stephen Schey, MD, Michelle Chen, Daniel Tannenbaum, B.S., Michaela R Reagan, PhD, Irene M. Ghobrial, MD, Yosef Landesman, PhD, Sharon Shacham, PhD MBA, Michael Kauffman, MD, PhD, Kenneth C. Anderson, MD, Yu-Tzu Tai, PhD
Journal: Blood
Blood (2012) 120 (21): 1835.
https://doi.org/10.1182/blood.V120.21.1835.1835
Published: 2012
Journal Articles

Targeting Aminopeptidases by Tosedostat (TST) (CHR2797), Alone and with LBH589, Induces Significant Cytotoxicity Against Human Multiple Myeloma (MM) Cells

Free
Chirag Acharya, Mike Y Zhong, B.S., Daniel Tannenbaum, B.S., Michelle Chen, Matt Ma, Jack Singer, MD, Kenneth C. Anderson, MD, Paul G. Richardson, MD, Yu-Tzu Tai, PhD
Journal: Blood
Blood (2012) 120 (21): 1847.
https://doi.org/10.1182/blood.V120.21.1847.1847
Published: 2012
Journal Articles

CRM1 Blockade by Novel Inhibitors of Nuclear Export (SINEs) Inhibits Multiple Myeloma Cell Growth, Osteoclastogenesis, and Myeloma-Induced Osteolysis

Free
Yu-Tzu Tai, PhD, Yosef Landesman, PhD, Chirag Acharya, M.D., Mike Y Zhong, B.S., Yolanda Calle, PhD, Michele Cea, MD, Yiguo Hu, PhD, Antonia Cagnetta, MD, Daniel Tannenbaum, B.S., Michelle Chen, Aditya Munshi, William Senapedis, PhD, Jean-Richard Saint-Martin, BS, Trinayan Kashyap, Haoqiang Ying, Dilara McCauley, PhD, Sharon Shacham, PhD MBA, Michael Kauffman, MD, PhD, Yumei Gu, Ph.D., Lizi Wu, PhD, Stephen Schey, MD, Andrew L. Kung, MD, PhD, Nikhil C. Munshi, MD, Paul G. Richardson, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2012) 120 (21): 326.
https://doi.org/10.1182/blood.V120.21.326.326
Published: 2012